Results 41 to 50 of about 119,463 (268)
Background Nearly 50% of patients undergoing maintenance hemodialysis are aged ≥ 60 years, highlighting a growing population with unique health challenges.
Jia Wanning +5 more
doaj +1 more source
Hongmei Zhao, Changgeng Liu, Lin Song, Weihui WangHemodialysis Department, People’s Hospital of Aba Tibetan and Qiang Autonomous Prefecture, Aba, Sichuan, People’s Republic of ChinaCorrespondence: Weihui Wang, Hemodialysis Department, People’s Hospital ...
Zhao H, Liu C, Song L, Wang W
doaj
Hemodialysis (HD) is a life-sustaining treatment for chronic kidney disease (CKD) patients. This study aimed to identify candidate diagnostic biomarkers associated with HD-treated CKD.
Guoxin Zhang, Jieqiong Fu, Wenming Niu
doaj +1 more source
Inherited metabolic epilepsies–established diseases, new approaches
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley +1 more source
Qiaoxia Chen, Juanjuan Chen, Yanjuan Teng Department of Nursing, Shanghai Sixth People’s Hospital, Shanghai, 200233, People’s Republic of ChinaCorrespondence: Yanjuan Teng, Department of Nursing, Shanghai Sixth People’s Hospital, 600 Yishan Road ...
Chen Q, Chen J, Teng Y
doaj
POS-699 BORDERLINE REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS: WHERE DOES THE TREATMENT STAND
M. MOJAAT +8 more
doaj +1 more source
The multiple hit model of infantile and epileptic spasms: The 2025 update
Abstract Objective Infantile and epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy manifesting with epileptic spasms and poor neurodevelopmental outcomes. There is an urgent need for the development of more effective and tolerated therapies.
Aristea S. Galanopoulou +6 more
wiley +1 more source
Porphyria cutanea tarda (PCT) is a rare disease, with a strong association with hepatitis C virus. PCT is particularly problematic in end-stage renal disease patients as they have no renal excretion of porphyrins and these are poorly dialyzed.
Natacha Rodrigues +4 more
doaj +1 more source

